SOC
SOC is a pharmaceutical drug with 54 clinical trials. Currently 18 active trials ongoing. Historical success rate of 82.1%.
Success Metrics
Based on 23 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
20
Mid Stage
11
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
79.3%
23 of 29 finished
20.7%
6 ended early
18
trials recruiting
54
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
Study of Flonoltinib Maleate Tablets in the Treatment of Severe Novel Coronavirus (COVID-19) Infection
Clinical Trials (54)
A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
Study of Flonoltinib Maleate Tablets in the Treatment of Severe Novel Coronavirus (COVID-19) Infection
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia
A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19.
Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
Effect of Telitacicept on Antibody Titers in Primary APS Patients
A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy
REFLECTION: A Clinical Practice Learning Program for Galleri®
Post Stroke Ambulation Recovery Using Robotic Exoskeletons
Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 54